Attention Deficit Hyperactivity Disorder: Selection of the Optimum Duration of Medical Treatment

A total of 32 children aged 6–12 years with attention deficit hyperactivity disorder (ADHD) were monitored during prolonged (6–8 months) treatment with Pantogam (homopantothenic acid) at daily doses of 500–1000 mg. Treatment results were assessed using the DSM-IV core ADHD symptom scales and the WFI...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience and behavioral physiology 2013-03, Vol.43 (3), p.346-350
Main Authors: Zavadenko, N. N., Suvorinova, N. Yu
Format: Article
Language:English
Subjects:
Acids
Adaptations
Attention deficit hyperactivity disorder
Behavior
Behavioral Sciences
Biomedical and Life Sciences
Biomedicine
Cognitive enhancement
Hyperactivity
Impulsivity
Medical treatment
Neurobiology
Neurosciences
Self esteem
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A total of 32 children aged 6–12 years with attention deficit hyperactivity disorder (ADHD) were monitored during prolonged (6–8 months) treatment with Pantogam (homopantothenic acid) at daily doses of 500–1000 mg. Treatment results were assessed using the DSM-IV core ADHD symptom scales and the WFIRS-P (parental) scale every two months. Decreases in core symptoms on the DSM-IV core ADHD symptom scale were seen at two months of treatment. Significant changes on the WFIRS-P scale took longer: improvements in self-concept, socialization, and social activity were seen at four months and in behavior and schoolwork, basic life skills, along with decreases in risk-associated behavior, at six months. Thus, in contrast to regression of core ADHD symptoms, overcoming impairments in social-psychological adaptation required longer treatment periods.
ISSN:0097-0549
1573-899X
DOI:10.1007/s11055-013-9738-8